-
1
-
-
81355164576
-
Breast cancer statistics
-
21969133 10.3322/caac.20134
-
DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):409-418
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.6
, pp. 409-418
-
-
Desantis, C.1
Siegel, R.2
Bandi, P.3
Jemal, A.4
-
2
-
-
62449131093
-
Supervised risk predictor of breast cancer based on intrinsic subtypes
-
19204204 10.1200/JCO.2008.18.1370
-
Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27(8):1160-1167
-
(2009)
J Clin Oncol
, vol.27
, Issue.8
, pp. 1160-1167
-
-
Parker, J.S.1
Mullins, M.2
Cheang, M.C.3
Leung, S.4
Voduc, D.5
Vickery, T.6
Davies, S.7
Fauron, C.8
He, X.9
Hu, Z.10
Quackenbush, J.F.11
Stijleman, I.J.12
Palazzo, J.13
Marron, J.S.14
Nobel, A.B.15
Mardis, E.16
Nielsen, T.O.17
Ellis, M.J.18
Perou, C.M.19
Bernard, P.S.20
more..
-
3
-
-
0034680102
-
Molecular portraits of human breast tumours
-
10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
-
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752
-
(2000)
Nature
, vol.406
, Issue.6797
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
Van De Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lonning, P.E.15
Borresen-Dale, A.L.16
Brown, P.O.17
Botstein, D.18
-
4
-
-
44249114098
-
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
-
18413639 10.1200/JCO.2007.14.4287
-
Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26(14):2373-2378
-
(2008)
J Clin Oncol
, vol.26
, Issue.14
, pp. 2373-2378
-
-
Nguyen, P.L.1
Taghian, A.G.2
Katz, M.S.3
Niemierko, A.4
Abi Raad, R.F.5
Boon, W.L.6
Bellon, J.R.7
Wong, J.S.8
Smith, B.L.9
Harris, J.R.10
-
5
-
-
4143150688
-
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
-
15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D
-
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367-5374
-
(2004)
Clin Cancer Res
, vol.10
, Issue.16
, pp. 5367-5374
-
-
Nielsen, T.O.1
Hsu, F.D.2
Jensen, K.3
Cheang, M.4
Karaca, G.5
Hu, Z.6
Hernandez-Boussard, T.7
Livasy, C.8
Cowan, D.9
Dressler, L.10
Akslen, L.A.11
Ragaz, J.12
Gown, A.M.13
Gilks, C.B.14
Van De Rijn, M.15
Perou, C.M.16
-
6
-
-
56949103031
-
What is triple-negative breast cancer?
-
19008097 10.1016/j.ejca.2008.09.034 1:CAS:528:DC%2BD1cXhsVKltr%2FE
-
Irvin WJ Jr, Carey LA (2008) What is triple-negative breast cancer? Eur J Cancer 44(18):2799-2805
-
(2008)
Eur J Cancer
, vol.44
, Issue.18
, pp. 2799-2805
-
-
Irvin, Jr.W.J.1
Carey, L.A.2
-
7
-
-
18244409687
-
Gene expression profiling predicts clinical outcome of breast cancer
-
10.1038/415530a
-
van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530-536
-
(2002)
Nature
, vol.415
, Issue.6871
, pp. 530-536
-
-
Van'T Veer, L.J.1
Dai, H.2
Van De Vijver, M.J.3
He, Y.D.4
Hart, A.A.5
Mao, M.6
Peterse, H.L.7
Van Der Kooy, K.8
Marton, M.J.9
Witteveen, A.T.10
Schreiber, G.J.11
Kerkhoven, R.M.12
Roberts, C.13
Linsley, P.S.14
Bernards, R.15
Friend, S.H.16
-
8
-
-
0042838307
-
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
-
12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D
-
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100(18):10393-10398
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.18
, pp. 10393-10398
-
-
Sotiriou, C.1
Neo, S.Y.2
McShane, L.M.3
Korn, E.L.4
Long, P.M.5
Jazaeri, A.6
Martiat, P.7
Fox, S.B.8
Harris, A.L.9
Liu, E.T.10
-
9
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D
-
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869-10874
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.19
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshirani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
Van De Rijn, M.9
Jeffrey, S.S.10
Thorsen, T.11
Quist, H.12
Matese, J.C.13
Brown, P.O.14
Botstein, D.15
Eystein Lonning, P.16
Borresen-Dale, A.L.17
-
10
-
-
41649102048
-
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
-
18250347 10.1200/JCO.2007.14.4147
-
Liedtke C, Mazouni C, Hess KR, Andre F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26(8):1275-1281
-
(2008)
J Clin Oncol
, vol.26
, Issue.8
, pp. 1275-1281
-
-
Liedtke, C.1
Mazouni, C.2
Hess, K.R.3
Andre, F.4
Tordai, A.5
Mejia, J.A.6
Symmans, W.F.7
Gonzalez-Angulo, A.M.8
Hennessy, B.9
Green, M.10
Cristofanilli, M.11
Hortobagyi, G.N.12
Pusztai, L.13
-
11
-
-
23844549918
-
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
-
16115903 10.1158/1078-0432.CCR-04-2421 1:CAS:528:DC%2BD2MXos1Cjs7k%3D
-
Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11(16):5678-5685
-
(2005)
Clin Cancer Res
, vol.11
, Issue.16
, pp. 5678-5685
-
-
Rouzier, R.1
Perou, C.M.2
Symmans, W.F.3
Ibrahim, N.4
Cristofanilli, M.5
Anderson, K.6
Hess, K.R.7
Stec, J.8
Ayers, M.9
Wagner, P.10
Morandi, P.11
Fan, C.12
Rabiul, I.13
Ross, J.S.14
Hortobagyi, G.N.15
Pusztai, L.16
-
12
-
-
33744960226
-
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
-
16757721 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D
-
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502
-
(2006)
JAMA
, vol.295
, Issue.21
, pp. 2492-2502
-
-
Carey, L.A.1
Perou, C.M.2
Livasy, C.A.3
Dressler, L.G.4
Cowan, D.5
Conway, K.6
Karaca, G.7
Troester, M.A.8
Tse, C.K.9
Edmiston, S.10
Deming, S.L.11
Geradts, J.12
Cheang, M.C.13
Nielsen, T.O.14
Moorman, P.G.15
Earp, H.S.16
Millikan, R.C.17
-
13
-
-
33750576185
-
Re-evaluating adjuvant breast cancer trials: Assessing hormone receptor status by immunohistochemical versus extraction assays
-
17077359 10.1093/jnci/djj415 1:CAS:528:DC%2BD28XhtFyqt7%2FL
-
Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurkula M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B (2006) Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst 98(21):1571-1581
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.21
, pp. 1571-1581
-
-
Regan, M.M.1
Viale, G.2
Mastropasqua, M.G.3
Maiorano, E.4
Golouh, R.5
Carbone, A.6
Brown, B.7
Suurkula, M.8
Langman, G.9
Mazzucchelli, L.10
Braye, S.11
Grigolato, P.12
Gelber, R.D.13
Castiglione-Gertsch, M.14
Price, K.N.15
Coates, A.S.16
Goldhirsch, A.17
Gusterson, B.18
-
14
-
-
0033959550
-
Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: Interlaboratory variance in the sensitivity of detection and evaluation of scoring systems
-
10767828 10.1136/jcp.53.2.125 1:STN:280:DC%2BD3c3jtVelsA%3D%3D
-
Rhodes A, Jasani B, Barnes DM, Bobrow LG, Miller KD (2000) Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 53(2):125-130
-
(2000)
J Clin Pathol
, vol.53
, Issue.2
, pp. 125-130
-
-
Rhodes, A.1
Jasani, B.2
Barnes, D.M.3
Bobrow, L.G.4
Miller, K.D.5
-
15
-
-
85047688517
-
Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma
-
12866377 10.1309/QPHDRB00QXGMUQ9N
-
Goldstein NS, Ferkowicz M, Odish E, Mani A, Hastah F (2003) Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol 120(1):86-92
-
(2003)
Am J Clin Pathol
, vol.120
, Issue.1
, pp. 86-92
-
-
Goldstein, N.S.1
Ferkowicz, M.2
Odish, E.3
Mani, A.4
Hastah, F.5
-
16
-
-
0037099732
-
Evaluation of HER-2/neu gene amplification and overexpression: Comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens
-
12118023 1:CAS:528:DC%2BD38XmtVCrtLk%3D
-
Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol 20(14):3095-3105
-
(2002)
J Clin Oncol
, vol.20
, Issue.14
, pp. 3095-3105
-
-
Press, M.F.1
Slamon, D.J.2
Flom, K.J.3
Park, J.4
Zhou, J.Y.5
Bernstein, L.6
-
17
-
-
0037024478
-
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
-
12048274 10.1093/jnci/94.11.855
-
Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA (2002) Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst 94(11):855-857
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.11
, pp. 855-857
-
-
Roche, P.C.1
Suman, V.J.2
Jenkins, R.B.3
Davidson, N.E.4
Martino, S.5
Kaufman, P.A.6
Addo, F.K.7
Murphy, B.8
Ingle, J.N.9
Perez, E.A.10
-
18
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
17159189 10.1200/JCO.2006.09.2775 1:CAS:528:DC%2BD2sXht1ejs7Y%3D
-
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145
-
(2007)
J Clin Oncol
, vol.25
, Issue.1
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
Dowsett, M.7
Fitzgibbons, P.L.8
Hanna, W.M.9
Langer, A.10
McShane, L.M.11
Paik, S.12
Pegram, M.D.13
Perez, E.A.14
Press, M.F.15
Rhodes, A.16
Sturgeon, C.17
Taube, S.E.18
Tubbs, R.19
Vance, G.H.20
Van De Vijver, M.21
Wheeler, T.M.22
Hayes, D.F.23
more..
-
19
-
-
1542469713
-
Measurement of gene expression in archival paraffin-embedded tissues: Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay
-
14695316 10.1016/S0002-9440(10)63093-3 1:CAS:528:DC%2BD2cXlsVChtA%3D%3D
-
Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, Esteban JM, Baker JB (2004) Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase- polymerase chain reaction assay. Am J Pathol 164(1):35-42
-
(2004)
Am J Pathol
, vol.164
, Issue.1
, pp. 35-42
-
-
Cronin, M.1
Pho, M.2
Dutta, D.3
Stephans, J.C.4
Shak, S.5
Kiefer, M.C.6
Esteban, J.M.7
Baker, J.B.8
-
20
-
-
9144242764
-
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
-
14728934 10.1016/S0959-8049(03)00675-0 1:CAS:528:DC%2BD2cXjsVOlsA%3D%3D
-
Petit T, Wilt M, Velten M, Millon R, Rodier JF, Borel C, Mors R, Haegele P, Eber M, Ghnassia JP (2004) Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. Eur J Cancer 40(2):205-211
-
(2004)
Eur J Cancer
, vol.40
, Issue.2
, pp. 205-211
-
-
Petit, T.1
Wilt, M.2
Velten, M.3
Millon, R.4
Rodier, J.F.5
Borel, C.6
Mors, R.7
Haegele, P.8
Eber, M.9
Ghnassia, J.P.10
-
21
-
-
23444450588
-
Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients
-
15976096 10.1373/clinchem.2004.044305 1:CAS:528:DC%2BD2MXlsleqsr4%3D
-
Tse C, Brault D, Gligorov J, Antoine M, Neumann R, Lotz JP, Capeau J (2005) Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients. Clin Chem 51(7):1093-1101
-
(2005)
Clin Chem
, vol.51
, Issue.7
, pp. 1093-1101
-
-
Tse, C.1
Brault, D.2
Gligorov, J.3
Antoine, M.4
Neumann, R.5
Lotz, J.P.6
Capeau, J.7
-
22
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
12490681 10.1056/NEJMoa021967
-
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999-2009
-
(2002)
N Engl J Med
, vol.347
, Issue.25
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
He, Y.D.2
Van'T Veer, L.J.3
Dai, H.4
Hart, A.A.5
Voskuil, D.W.6
Schreiber, G.J.7
Peterse, J.L.8
Roberts, C.9
Marton, M.J.10
Parrish, M.11
Atsma, D.12
Witteveen, A.13
Glas, A.14
Delahaye, L.15
Van Der Velde, T.16
Bartelink, H.17
Rodenhuis, S.18
Rutgers, E.T.19
Friend, S.H.20
Bernards, R.21
more..
-
23
-
-
42949093222
-
Quantitative PCR and HER2 testing in breast cancer: A technical and cost-effectiveness analysis
-
18343783 10.1309/1AKQDQ057PQT9AKX
-
Barberis M, Pellegrini C, Cannone M, Arizzi C, Coggi G, Bosari S (2008) Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis. Am J Clin Pathol 129(4):563-570
-
(2008)
Am J Clin Pathol
, vol.129
, Issue.4
, pp. 563-570
-
-
Barberis, M.1
Pellegrini, C.2
Cannone, M.3
Arizzi, C.4
Coggi, G.5
Bosari, S.6
-
24
-
-
33750310901
-
REporting recommendations for tumor MARKer prognostic studies (REMARK)
-
16932852 10.1007/s10549-006-9242-8
-
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229-235
-
(2006)
Breast Cancer Res Treat
, vol.100
, Issue.2
, pp. 229-235
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
25
-
-
34548148743
-
Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer
-
17651454 10.1111/j.1349-7006.2007.00565.x 1:CAS:528:DC%2BD2sXhtF2qtb%2FL
-
Li X, Cao X, Zhang W, Feng Y (2007) Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer. Cancer Sci 98(10):1592-1596
-
(2007)
Cancer Sci
, vol.98
, Issue.10
, pp. 1592-1596
-
-
Li, X.1
Cao, X.2
Zhang, W.3
Feng, Y.4
-
26
-
-
85027940310
-
CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
-
21717105 10.1007/s10549-011-1647-3 1:CAS:528:DC%2BC3MXht1yktL3J
-
Liu F, Lang R, Zhao J, Zhang X, Pringle GA, Fan Y, Yin D, Gu F, Yao Z, Fu L (2011) CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 130(2):645-655
-
(2011)
Breast Cancer Res Treat
, vol.130
, Issue.2
, pp. 645-655
-
-
Liu, F.1
Lang, R.2
Zhao, J.3
Zhang, X.4
Pringle, G.A.5
Fan, Y.6
Yin, D.7
Gu, F.8
Yao, Z.9
Fu, L.10
-
27
-
-
79958280134
-
RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues
-
21370017 10.1007/978-1-61779-055-3-15 1:CAS:528:DC%2BC3MXntlynsL8%3D
-
Scott A, Ambannavar R, Jeong J, Liu ML, Cronin MT (2011) RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues. Methods Mol Biol 724:239-257
-
(2011)
Methods Mol Biol
, vol.724
, pp. 239-257
-
-
Scott, A.1
Ambannavar, R.2
Jeong, J.3
Liu, M.L.4
Cronin, M.T.5
-
28
-
-
79952167236
-
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue - A new option for predictive biomarker assessment in breast cancer
-
21326033 10.1097/PDM.0b013e3181e3630c
-
Muller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, Weichert W, Altmann G, Roth C, Winzer KJ, Kristiansen G, Petry C, Dietel M, Denkert C (2011) Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue-a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol 20(1):1-10
-
(2011)
Diagn Mol Pathol
, vol.20
, Issue.1
, pp. 1-10
-
-
Muller, B.M.1
Kronenwett, R.2
Hennig, G.3
Euting, H.4
Weber, K.5
Bohmann, K.6
Weichert, W.7
Altmann, G.8
Roth, C.9
Winzer, K.J.10
Kristiansen, G.11
Petry, C.12
Dietel, M.13
Denkert, C.14
-
29
-
-
64249114629
-
A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens
-
19225135 10.2353/jmoldx.2009.080070 1:CAS:528:DC%2BD1MXjs12qs7g%3D
-
Iverson AA, Gillett C, Cane P, Santini CD, Vess TM, Kam-Morgan L, Wang A, Eisenberg M, Rowland CM, Hessling JJ, Broder SE, Sninsky JJ, Tutt A, Anderson S, Chang SY (2009) A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens. J Mol Diagn 11(2):117-130
-
(2009)
J Mol Diagn
, vol.11
, Issue.2
, pp. 117-130
-
-
Iverson, A.A.1
Gillett, C.2
Cane, P.3
Santini, C.D.4
Vess, T.M.5
Kam-Morgan, L.6
Wang, A.7
Eisenberg, M.8
Rowland, C.M.9
Hessling, J.J.10
Broder, S.E.11
Sninsky, J.J.12
Tutt, A.13
Anderson, S.14
Chang, S.Y.15
-
30
-
-
79151470854
-
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: Prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)
-
21190079 10.1007/s10549-010-1316-y 1:CAS:528:DC%2BC3MXpvFWhtg%3D%3D
-
Noske A, Loibl S, Darb-Esfahani S, Roller M, Kronenwett R, Muller BM, Steffen J, von Toerne C, Wirtz R, Baumann I, Hoffmann G, Heinrich G, Grasshoff ST, Ulmer HU, Denkert C, von Minckwitz G (2011) Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Res Treat 126(1):109-117
-
(2011)
Breast Cancer Res Treat
, vol.126
, Issue.1
, pp. 109-117
-
-
Noske, A.1
Loibl, S.2
Darb-Esfahani, S.3
Roller, M.4
Kronenwett, R.5
Muller, B.M.6
Steffen, J.7
Von Toerne, C.8
Wirtz, R.9
Baumann, I.10
Hoffmann, G.11
Heinrich, G.12
Grasshoff, S.T.13
Ulmer, H.U.14
Denkert, C.15
Von Minckwitz, G.16
-
31
-
-
33750598939
-
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer
-
17008703 10.1200/JCO.2006.06.6944 1:CAS:528:DC%2BD28XhtFemtrbF
-
Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG (2006) The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 24(28):4611-4619
-
(2006)
J Clin Oncol
, vol.24
, Issue.28
, pp. 4611-4619
-
-
Ma, X.J.1
Hilsenbeck, S.G.2
Wang, W.3
Ding, L.4
Sgroi, D.C.5
Bender, R.A.6
Osborne, C.K.7
Allred, D.C.8
Erlander, M.G.9
-
32
-
-
45149107241
-
Estrogen- and progesterone-receptor status in ECOG 2197: Comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory
-
18487567 10.1200/JCO.2007.13.6424
-
Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA (2008) Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 26(15):2473-2481
-
(2008)
J Clin Oncol
, vol.26
, Issue.15
, pp. 2473-2481
-
-
Badve, S.S.1
Baehner, F.L.2
Gray, R.P.3
Childs, B.H.4
Maddala, T.5
Liu, M.L.6
Rowley, S.C.7
Shak, S.8
Perez, E.A.9
Shulman, L.J.10
Martino, S.11
Davidson, N.E.12
Sledge, G.W.13
Goldstein, L.J.14
Sparano, J.A.15
-
33
-
-
11944254572
-
Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units
-
15499614 10.1002/ijc.20632 1:CAS:528:DC%2BD2MXnvFGhuw%3D%3D
-
Gobbi H, Dupont WD, Parl FF, Schuyler PA, Plummer WD, Olson SJ, Page DL (2005) Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units. Int J Cancer 113(5):857-859
-
(2005)
Int J Cancer
, vol.113
, Issue.5
, pp. 857-859
-
-
Gobbi, H.1
Dupont, W.D.2
Parl, F.F.3
Schuyler, P.A.4
Plummer, W.D.5
Olson, S.J.6
Page, D.L.7
-
34
-
-
0009941731
-
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
-
10888772 1:STN:280:DC%2BD3czptVKrtQ%3D%3D
-
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):966-978
-
(2000)
Arch Pathol Lab Med
, vol.124
, Issue.7
, pp. 966-978
-
-
Fitzgibbons, P.L.1
Page, D.L.2
Weaver, D.3
Thor, A.D.4
Allred, D.C.5
Clark, G.M.6
Ruby, S.G.7
O'Malley, F.8
Simpson, J.F.9
Connolly, J.L.10
Hayes, D.F.11
Edge, S.B.12
Lichter, A.13
Schnitt, S.J.14
-
35
-
-
1042301335
-
Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: A comparison of manual and computer-assisted scoring methods
-
15129906 10.1016/j.anndiagpath.2003.11.004
-
Diaz LK, Sahin A, Sneige N (2004) Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods. Ann Diagn pathol 8(1):23-27
-
(2004)
Ann Diagn Pathol
, vol.8
, Issue.1
, pp. 23-27
-
-
Diaz, L.K.1
Sahin, A.2
Sneige, N.3
-
36
-
-
10844268872
-
Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma
-
15565575 10.1002/cncr.20761 1:CAS:528:DC%2BD2MXmtVartA%3D%3D
-
Fisher ER, Anderson S, Dean S, Dabbs D, Fisher B, Siderits R, Pritchard J, Pereira T, Geyer C, Wolmark N (2005) Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer 103(1):164-173
-
(2005)
Cancer
, vol.103
, Issue.1
, pp. 164-173
-
-
Fisher, E.R.1
Anderson, S.2
Dean, S.3
Dabbs, D.4
Fisher, B.5
Siderits, R.6
Pritchard, J.7
Pereira, T.8
Geyer, C.9
Wolmark, N.10
-
37
-
-
84861879944
-
Semi-quantitative immunohistochemical assay versus oncotype DX((R)) qRT-PCR assay for estrogen and progesterone receptors: An independent quality assurance study
-
22301704 10.1038/modpathol.2011.219 1:CAS:528:DC%2BC38XnvFeku70%3D
-
Kraus JA, Dabbs DJ, Beriwal S, Bhargava R (2012) Semi-quantitative immunohistochemical assay versus oncotype DX((R)) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study. Mod Pathol 25(6):869-876
-
(2012)
Mod Pathol
, vol.25
, Issue.6
, pp. 869-876
-
-
Kraus, J.A.1
Dabbs, D.J.2
Beriwal, S.3
Bhargava, R.4
-
38
-
-
0018728250
-
Prognostic value of estrogen receptors in primary breast cancer
-
476576 10.1002/1097-0142(197908)44:2<671: AID-CNCR2820440238>3.0. CO;2-V 1:STN:280:DyaL3c%2FgtFCqtQ%3D%3D
-
Hahnel R, Woodings T, Vivian AB (1979) Prognostic value of estrogen receptors in primary breast cancer. Cancer 44(2):671-675
-
(1979)
Cancer
, vol.44
, Issue.2
, pp. 671-675
-
-
Hahnel, R.1
Woodings, T.2
Vivian, A.B.3
-
39
-
-
42549116694
-
Current issues in ER and HER2 testing by IHC in breast cancer
-
18437174 10.1038/modpathol.2008.34 1:CAS:528:DC%2BD1cXltFehsr8%3D
-
Gown AM (2008) Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 21(Suppl 2):S8-S15
-
(2008)
Mod Pathol
, vol.21
, Issue.SUPPL. 2
-
-
Gown, A.M.1
|